Reuters logo
BRIEF-Recro Pharma announces FDA acceptance for review of new drug application for IV Meloxicam 30mg
2017年9月28日 / 上午11点24分 / 1 个月前

BRIEF-Recro Pharma announces FDA acceptance for review of new drug application for IV Meloxicam 30mg

Sept 28 (Reuters) - Recro Pharma Inc

* Recro Pharma announces FDA acceptance for review of new drug application for IV Meloxicam 30mg Source text for Eikon: Further company coverage: (Bangalore.newsroom@thomsonreuters.com)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below